The authors’ investigations showed that PD-1 gene expression and 12 signatures connected to T-cell, and NK cell activation were associated with non-progressive disease and better PFS regardless of tumor type, treatment, or biopsy time [76]. The gene discussed is PDCD1; the disease is neoplasm.